NDC 14335-472-01 - Cyclophosphamide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 14335-472
Requested NDC: 14335-472-01
Package NDCs from labels: 14335-472-01, 14335-472-10
Manufacturer: Hainan Poly Pharm. Co., Ltd.
Effective date: 2025-01-03
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Cyclophosphamide for Injection - Hainan Poly Pharm. Co., Ltd.	Hainan Poly Pharm. Co., Ltd.	2025-01-03	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
14335-472-01	Cyclophosphamide	100 mL in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, FOR SOLUTION	100		1
14335-472-10	Cyclophosphamide	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
14335-472	CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE FOR INJECTION) INJECTION, POWDER, FOR SOLUTION [HAINAN POLY PHARM. CO., LTD.]	1	Current NDC, 2 package rows	20250104_6fde2705-a2d8-4d48-9618-b9d99d051373.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cyclophosphamide	CYCLOPHOSPHAMIDE	Alembic Pharmaceuticals Inc.	3d6e68b1-5120-4cbb-a9d2-fb09d1b74ea1	2024-12-10	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	NorthStar Rx LLC	76f057be-e3da-0a89-e053-2a91aa0a8438	2024-11-20	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Hikma Pharmaceuticals USA Inc.	8135b917-882f-4b4c-99b7-fa8ea54af4bf	2024-11-19	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Fresenius Kabi USA, LLC	31986d36-a1bf-4903-93a4-ce7386241ba1	2024-10-09	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Avyxa Pharma, LLC	6f593585-e0dd-48bc-bd2b-c6c787e0b98c	2024-07-26	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE INJECTION, SOLUTION	Baxter Healthcare Company	34dbffee-80e0-49c3-90e8-95713a0b7fbe	2024-04-10	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
Cyclophosphamide	CYCLOPHOSPHAMIDE	Baxter Healthcare Corporation	769ded74-6186-40a8-8e44-ceff67287451	2020-08-07	Warnings, Adverse reactions	Exact identifier unii: 8N3DW7272P
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	cef038cc-efab-46d9-99c2-95bb11d6c9bc	2017-03-15	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	6bae5c14-9e87-4fb6-ae9c-4d875c1ecffe	2017-03-15	Warnings, Adverse reactions	Exact identifier rxcui: 1734921 rxcui: 1734917 rxcui: 1734919 unii: 8N3DW7272P

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.